SCHOENBERG MARK (Chief Medical Officer) sold 1.4% of their position (871.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $37.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2026ACC: 0001437749-26-029965
Officer· Chief Medical Officer
Since Jan 2019
-871.00
Net shares
Net seller
$37.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.67K acquired · 2.54K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.67K
Price / share
—
Trade value
—
% of position
2.8%
9/7/2026
59.09K→60.75K
Ordinary Shares
Direct
Shares
−871.00
Price / share
$42.92
Trade value
$37.38K
% of position
1.4%
9/8/2026
60.75K→59.88K
Total
Net shares
+796.00
Net value
-$37.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/7/2026 | M · Option Exercise | +1.67K | — | — | 2.8% | 59.09K | 60.75K |
| Ordinary Shares Direct | 9/8/2026 | S · Sale | −871.00 | $42.92 | $37.38K | 1.4% | 60.75K | 59.88K |
| Total | +796.00 | -$37.38K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
1.67K shares
Shares
−1.67K
Strike price
Held after
0.00
Exercisable
—
9/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares1.67K shares | 9/7/2026 | M · Option Exercise | −1.67K | — | 0.00 |